Gene-Specific Template (Updated 9-28-21): Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Under Construction}}
{{Under Construction}}


(''General Instructions –The main focus of these pages is providing a quick reference for cancer associations and linking to internal and external resources providing genetics-related information for the gene of interest. Use [https://www.genenames.org/ <u>HUGO-approved gene names and symbols</u>] (italicized when appropriate), [https://varnomen.hgvs.org/recommendations/DNA/ <u>HGVS-based nomenclature for variants</u>], as well as generic names of drugs and testing platforms or assays if applicable. Please complete tables whenever possible and do not delete them. The use of bullet points rather than large paragraphs is encouraged. Additional instructions below in italicized blue text should not be included in the final page content. Please also see [[Author Instructions|<u>Author Instructions</u>]] and [[Frequently Asked Questions (FAQs)|<u>FAQs</u>]] as well as contact your [[Leadership|<u>Associate Editor</u>]] or [Mailto:CCGA@cancergenomics.org <u>Technical Support</u>].'')
(''General Instructions –The main focus of these pages is providing a quick reference for cancer associations and linking to internal and external resources providing genetics-related information for the gene of interest. Use [https://www.genenames.org/ <u>HUGO-approved gene names and symbols</u>] (italicized when appropriate), [https://varnomen.hgvs.org/recommendations/DNA/ <u>HGVS-based nomenclature for variants</u>], as well as generic names of drugs and testing platforms or assays if applicable. Please complete tables whenever possible and do not delete them. The use of bullet points rather than large paragraphs is encouraged. Additional instructions below in italicized blue text should not be included in the final page content. Please also see [[Author Instructions|<u>Author Instructions</u>]] , [[How to Curate a Gene Page|<u>How to Curate a Gene Page</u>]], and [[Frequently Asked Questions (FAQs)|<u>FAQs</u>]] as well as contact your [[Leadership|<u>Associate Editor</u>]] or [Mailto:CCGA@cancergenomics.org <u>Technical Support</u>].'')


==Primary Author(s)*==
==Primary Author(s)*==
Line 97: Line 97:
==External Links==
==External Links==


Put your text here - Include as applicable links to:  
Put your text here (''Instruction: Include as applicable links to: ''
1) Atlas of Genetics and Cytogenetics in Oncology and Haematology,  
1) Atlas of Genetics and Cytogenetics in Oncology and Haematology,  
2) COSMIC,  
2) COSMIC,  
Line 114: Line 114:
15) TICdb - database of Translocation breakpoints In Cancer
15) TICdb - database of Translocation breakpoints In Cancer
16) GeneReviews,  
16) GeneReviews,  
17) ClinGen, and 18) Any gene-specific databases.
17) ClinGen, and 18) Any gene-specific databases''.)''


EXAMPLES (these may be filled in already)
EXAMPLES (these may be filled in already and if not, click on the link and select edit to change)


'''[http://atlasgeneticsoncology.org/Genes/P53ID88.html ''TP53'' by Atlas of Genetics and Cytogenetics in Oncology and Haematology]''' - detailed gene information
'''[http://atlasgeneticsoncology.org/Genes/P53ID88.html ''TP53'' by Atlas of Genetics and Cytogenetics in Oncology and Haematology]''' - detailed gene information
Line 159: Line 159:


==References==
==References==
(use "Cite" icon at top of page for automatic insertion using PMID; ''If a PMID is not available, manually add the reference information such as for the example book or internet resource below'')<references />
(''Instruction: Use "Cite" icon at top of page for automatic insertion using PMID;'' ''If a PMID is not available, manually add the reference information such as for the example book or internet resource below'')<references />
===EXAMPLE Book===
===EXAMPLE Book===